Mild Cognitive Impairment
Neurology·MeSH: Cognitive Dysfunction
5 drugs in development·4 companies·25 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Kisunla | ELI LILLY & Co (LLY) |
Phase 3(1)
| Drug | Company |
|---|---|
| canakinumab | Novartis AG (NVS) |
Phase 2(1)
Phase 1(1)
| Drug | Company |
|---|---|
| BIIB080 | BIOGEN INC. (BIIB) |
Phase 4(1)
| Drug | Company |
|---|---|
| canakinumab | Novartis AG (NVS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Mild Cognitive Impairment?
BioSniper tracks 5 drugs in development for Mild Cognitive Impairment across 4 companies.
How many clinical trials target Mild Cognitive Impairment?
There are 25 clinical trials targeting Mild Cognitive Impairment tracked by BioSniper.
Deep-dive into Mild Cognitive Impairment
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis